rvallee
Senior Member (Voting Rights)
Last edited by a moderator:
Sleep studies are welcome but not a lot of info on the methods here. Will they be studying different phenotypes separately? Some of us have hypersomnia, others assorted types of insomnia, and for some sleep problems only show up - with a vengeance - after overexertion. Throwing all of that into one big pot may result in the pooled findings looking 'normal' even if each and every individual's sleep is anything but.
What in the name... insomnia is not a mental health problem, it is physical. I've had my ME made permanently worse by insomnia. I've been taking zopiclone since 2009. If you tell people that sleep problems are a mental health issue they will treat it as if it is inconsequential, and the patient's condition will deteriorate as I have experienced.There is a big drive here to move milder forms of mental health problems like insomnia
What in the name... insomnia is not a mental health problem, it is physical. I've had my ME made permanently worse by insomnia. I've been taking zopiclone since 2009. If you tell people that sleep problems are a mental health issue they will treat it as if it is inconsequential, and the patient's condition will deteriorate as I have experienced.
There is nothing mild about my insomnia.
I have an unusual pattern to my sleep and ME, every autumn, even though my ME is stable, I will have a relapse.
GPs should consider offering patients with insomnia the Sleepio app as an effective and cost saving alternative to sleeping pills, the National Institute for Health and Care Excellence (NICE) has recommended.1
The app will also reduce patients’ reliance on drugs such as zolpidem and zopiclone that can be dependence forming, said NICE’s medical technologies advisory committee.
The Sleepio app uses an artificial intelligence algorithm to provide tailored cognitive behavioural therapy for insomnia (CBT-I). It is primarily accessed through a website, and there is a Sleepio app for IOS mobile and Android devices.
CBT is what we call an 'evidence-based therapy', meaning that it has been shown to be effective in controlled scientific clinical studies. The earliest research in fact goes back more than 30 years, so several decades of evidence has accumulated to show that CBT can teach people how to fall asleep faster, stay asleep and feel better during the day.
'Randomized Controlled Trials' (or RCTs) are the gold standard method for evaluating whether a treatment is effective. Participants are randomly allocated to receive the treatment in question, no treatment or, in some cases, a placebo (ie. false but convincing) treatment. By comparing differences between groups we can confidently assess whether the real treatment truly works, and confirm that any improvements are not down to chance, some other external factor such as changes in the weather, or to people just believing they will get better. CBT for insomnia has been assessed in over 100 RCTs, and the results show that on average 70% of people with even very long term poor sleep obtain lasting benefit from the treatment.
100%. It's a blatant market grab, building up a market for a product they've got warehouses and a huge supply chain of. There are plenty of good apps for meditation that work far better than this junk. CBT is all about thinking and falling asleep is the opposite.CBT for insomnia is a joke. I'm left wondering about what tricks they used to give the illusion of success, we've seen them do it with exercise and I'm betting this is no different.
There has never been a single RCT of CBT. Because you can't control for it, it's an active thing. They're clinical trials, and especially bad ones at that since they are comically biased towards not just finding but producing an effect, and routinely report one even when there isn't.'Randomized Controlled Trials' (or RCTs) are the gold standard method for evaluating whether a treatment is effective
The cost of Sleepio is £45 (excluding VAT) per person who starts session 1 of the Sleepio programme. This price was proposed at consultation and differs from the previous cost models proposed by the company, which depended on regional uptake of Sleepio. The 2 previous cost models, the population-based and the tiered licence-based cost model, are outlined below.
2.10 The population-based cost model involved a cost per head per year depending on the size of the population within a region. This cost was independent of the number of people that used Sleepio. The larger the population, the lower the cost per head. Because a fixed price is paid by NHS organisations each year, increased uptake led to an increase in cost savings.
2.11 The tiered licence-based cost model was based on the number of people who had treatment with Sleepio. This was a tiered pricing system, so the cost per patient reduced as uptake increased beyond the number of people specified within each of the fixed tiers. For more details of these prices, see the supporting documents for Sleepio on the NICE website.
For more details about the technology, see the website for Sleepio.
discussion on BBC Radio2 with Dr Sarah Jarvis.
https://www.bbc.co.uk/programmes/m001pfzv
One person came off Zopiclone using melatonin. Interesting to hear the NHS position on use of melatonin.
Dr Jarvis highly recommends CBT.
The app recommended by NICE is called Sleepio.
Insomnia: NICE recommends digital app as treatment option
https://www.bmj.com/content/377/bmj.o1268
https://www.sleepio.com/cbt-for-insomnia/
Anyone else in the same boat and/or offering suggestions?
And perimenopause has just made it worse.